메뉴 건너뛰기




Volumn 113, Issue 1, 2006, Pages 141-143

An intriguing case of primary amyloidosis with cardiac involvement: Symptomatic and echocardiographic improvement with thalidomide treatment

Author keywords

Cardiac function; Primary amyloidosis; Thalidomide

Indexed keywords

DEXAMETHASONE; DIURETIC AGENT; THALIDOMIDE;

EID: 33750491953     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.09.046     Document Type: Article
Times cited : (9)

References (9)
  • 1
    • 0029939944 scopus 로고    scopus 로고
    • Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only
    • Skinner M., Anderson J., Simms R., et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 100 (1996) 290-298
    • (1996) Am J Med , vol.100 , pp. 290-298
    • Skinner, M.1    Anderson, J.2    Simms, R.3
  • 3
    • 1042288322 scopus 로고    scopus 로고
    • Therapy for immunoglobulin light chain amyloidosis: the new and the old
    • Gertz M.A., Lacy M.Q., and Dispenzieri A. Therapy for immunoglobulin light chain amyloidosis: the new and the old. Blood Rev 18 (2004) 17-37
    • (2004) Blood Rev , vol.18 , pp. 17-37
    • Gertz, M.A.1    Lacy, M.Q.2    Dispenzieri, A.3
  • 4
    • 0030895545 scopus 로고    scopus 로고
    • A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine
    • Kyle R.A., Gertz M.A., Greipp P.R., et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 336 (1997) 1202-1207
    • (1997) N Engl J Med , vol.336 , pp. 1202-1207
    • Kyle, R.A.1    Gertz, M.A.2    Greipp, P.R.3
  • 5
    • 0029094670 scopus 로고
    • New drug therapy of amyloidoses: resorption of AL-type deposits with 4′-iodo-4′-deoxydoxorubicin
    • Gianni L., Bellotti V., Gianni A.M., and Merlini G. New drug therapy of amyloidoses: resorption of AL-type deposits with 4′-iodo-4′-deoxydoxorubicin. Blood 86 (1995) 855-861
    • (1995) Blood , vol.86 , pp. 855-861
    • Gianni, L.1    Bellotti, V.2    Gianni, A.M.3    Merlini, G.4
  • 6
    • 2342591289 scopus 로고    scopus 로고
    • Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study
    • Dispenzieri A., Kyle R.A., Lacy M.Q., et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood 103 (2004) 3960-3963
    • (2004) Blood , vol.103 , pp. 3960-3963
    • Dispenzieri, A.1    Kyle, R.A.2    Lacy, M.Q.3
  • 8
    • 85112379092 scopus 로고    scopus 로고
    • Thalidomide is an effective agent for patients with primary amyloidosis (abstract)
    • Vescio R.A., and Berenson J.R. Thalidomide is an effective agent for patients with primary amyloidosis (abstract). Blood 96 11 part 2 (2000) 296b
    • (2000) Blood , vol.96 , Issue.11 PART 2
    • Vescio, R.A.1    Berenson, J.R.2
  • 9
    • 79960970720 scopus 로고    scopus 로고
    • A phase I/II trial of thalidomide for patients with AL amyloidosis (abstract)
    • Seldin D.C., Choufani E., Skinner M., et al. A phase I/II trial of thalidomide for patients with AL amyloidosis (abstract). Blood 98 11 part 1 (2001) 164a
    • (2001) Blood , vol.98 , Issue.11 PART 1
    • Seldin, D.C.1    Choufani, E.2    Skinner, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.